According to Lipella Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ0.51. In 2022 the company made an earnings per share (EPS) of -ยฃ0.36 a decrease over its 2021 EPS that were of -ยฃ0.26.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.53 | 48.54% |
2022 | -ยฃ0.36 | 39.25% |
2021 | -ยฃ0.26 |